Cellebrite DI Ltd. provided revenue guidance for the full year 2022. for the year, the company's revenue is expected to be between $285 and $300 million, representing 16-22% year on year growth.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.44 USD | -1.92% | -4.77% | +21.07% |
05-24 | JPMorgan Adjusts Price Target on Cellebrite DI to $14 From $12, Maintains Overweight Rating | MT |
05-24 | Deutsche Bank Adjusts Price Target on Cellebrite to $15 From $13, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.07% | 2.19B | |
+9.16% | 3,085B | |
+7.21% | 85.92B | |
+3.88% | 77.91B | |
-16.81% | 52.89B | |
+24.35% | 48.28B | |
+28.76% | 45.38B | |
-33.41% | 40.83B | |
+70.94% | 38.78B | |
+0.65% | 27.48B |
- Stock Market
- Equities
- CLBT Stock
- News Cellebrite DI Ltd.
- Cellebrite DI Ltd. Provides Revenue Guidance for the Full Year 2022